Celltrion USA Signs Agreement With Express Scripts for Its Therapy for Autoimmune Diseases Including the First FDA-Approved Subcutaneous Infliximab Zymfentra™
Celltrion USA与其自身免疫性疾病的快速脚本签署协议,包括首款经美国食品药品管理局批准的皮下英夫利昔单抗Zymfentra™
Celltrion USA Signs Agreement With Express Scripts for Its Therapy for Autoimmune Diseases Including the First FDA-Approved Subcutaneous Infliximab Zymfentra™
Celltrion USA与其自身免疫性疾病的快速脚本签署协议,包括首款经美国食品药品管理局批准的皮下英夫利昔单抗Zymfentra™
使用浏览器的分享功能,分享给你的好友吧